Advisory Committees
Roster of the Risk Communication Advisory Committee to the Food and Drug Administration
Applying for Membership on FDA Advisory Committees As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees. Current Number of Vacancies 1 |
| Chair Ellen M. Peters, Ph.D. Expertise: Risk Communication and Decisions, Numeracy Term: 10/01/2011 – 09/30/2015 Professor The Ohio State University Psychology Department, 235 Psychology Building 1835 Neil Avenue Columbus, OH 43210 | Designated Federal Officer (DFO) |
Noel T. Brewer, Ph.D. Mary L. Brown, Ph.D. Nananda Col, M.D., M.P.P., M.P.H., F.A.C.P. Moshe Engelberg, Ph.D.,M.P.H. Angela T. Fagerlin, Ph.D. Vicki S. Freimuth, Ph.D. | Jeremy N. Kees, Ph.D. Daniel G. Morrow, Ph.D. William K. Hallman, Ph.D. Gavin Huntley-Fenner, Ph.D. Kala L. Paul, M.D. Valerie Reyna, Ph.D. Expertise: Psychosocial and community health, health education, nursing Term: 10/01/2012 – 09/30/2016 Associate Professor, Psychosocial and Community Health University of Washington School of Nursing Box 357263 Seattle, WA 98195
* As described in the charter for this committee, the membership includes no single designated consumer representative, but several voting members with experiential knowledge of risk communication including patient and consumer perspectives. Also as described in the charter, the membership includes no single designated industry representative, the Commissioner or designee may select an industry representative from a group of individuals nominated by industry to serve temporarily as nonvoting members who are identified with industry interests. |
Updated February 16, 2012







